Showing results (641-650 of 2,937) with videos related to
Sort By:
Pageof 294
Cancer Investigation|January 1, 1988
High-dose folinic acid and 5-fluorouracil in advanced colorectal cancerF Di Costanzo, R Bartolucci, D Padalino, et al.Cancer Investigation|February 21, 2015
MicroRNA-138 Regulates DNA Damage Response in Small Cell Lung Cancer Cells by Directly Targeting H2AXHuan Yang, Jinwen Luo, Zhiguang Liu, et al.Cancer Investigation|January 23, 2015
The association between NQO1 Pro187Ser polymorphism and urinary system cancer susceptibility: a meta-analysis of 22 studiesYan Zhang, Dong Yang, Jin-Hong Zhu, et al.Cancer Investigation|January 24, 2015
Mutational profiling of second primary lung cancers in patients who have received radiation for the treatment of Hodgkin's diseaseDavid Alan Bond, Neil Dunavin, Gregory Alan OttersonCancer Investigation|June 7, 2014
Case-control study of breast cancer in India: Role of PERIOD3 clock gene length polymorphism and chronotypeMichael D Wirth, James B Burch, James R Hébert, et al.Cancer Investigation|January 1, 1990
Phase II trial of methyl-gag and melphalan in metastatic adult renal cell carcinomaJ L Guimaraes, M Ghosn, M Ostronoff, et al.Cancer Investigation|August 31, 2012
Buthionine sulfoximine and 1,25-dihydroxyvitamin D induce apoptosis in breast cancer cells via induction of reactive oxygen speciesLuciana P Bohl, Ana C Liaudat, Gabriela Picotto, et al.Cancer Investigation|August 23, 2012
Quantitative assessment of CYP1A1*2A variations with oral carcinoma susceptibility: evidence from 1,438 cases and 2,086 controlsXianlu Zhuo, Houyu Zhao, Aoshuang Chang, et al.Cancer Investigation|March 24, 2010
The role of irreversible EGFR inhibitors in the treatment of non-small cell lung cancer: overcoming resistance to reversible EGFR inhibitorsChandra P BelaniCancer Investigation|July 29, 1998
A comparison of efficacy of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in the therapeutic setting of chemotherapy-induced myelosuppressionR A Beveridge, J A Miller, A N Kales, et al.Pageof 294